Medical Affairs Plans: From Strategic Planning to Measuring Impact — Episode 3
Listeners will understand how the Medical Affairs strategic planning process can drive decision making throughout the year.
Listeners will understand how the Medical Affairs strategic planning process can drive decision making throughout the year.
Participants will learn the functions and activities of key internal partners and will identify potential areas for compliant collaboration with these partners.
In partnership with experts from Open Health and Janssen EMEA, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training.
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.
The Series Podcast Objectives are:
Podcast objectives include understanding how the medical affairs strategic planning process can drive decision making throughout the year
Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.
Nothing could stand between Joseph Eid and his dream of becoming a doctor—not even gunfire.
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Real-World Evidence can show safety and effectiveness per FDA’s “totality of evidence approach” for evaluating regulatory submissions.
This Medical Affairs Professional Society (MAPS) podcast features medical affairs thought leaders offering insights into the Medical Affairs strategic planning process